US drug maker Eli Lilly is cutting its investment in a German factory by half. This decision follows new healthcare cost-cutting laws in Germany. The company CEO called the reforms a bad signal for the industry. This move impacts Germany’s industrial plans. The factory will now operate at reduced capacity with fewer jobs. Other companies are also reconsidering local investments.
IIT-Roorkee's inaugural Data Science and AI BTech batch achieved 100% placements, with students securing roles…
AJUP founder Humayun Kabir has offered Mamata Banerjee a path back to the West Bengal…
On International MPS Awareness Day 2026, Rajya Sabha Deputy Chairman Harivansh launched "SHAURYA: A Father's…
An IRGC commander declared Israel's elimination achievable, backing Hezbollah amid regional tensions. Meanwhile, TMC rebels…
India has become the world's second-largest market for annual solar capacity additions, surpassing the US…
An African couple undergoing IVF treatment in Delhi were found dead in each other's arms…